Professional Seminar “Diversity of oligonucleotide therapeutics modalities” will be held by Nikkei Biotech at AP Nihonbashi on November 21, 2019.
Our President & CEO, Mr. Hideaki Sato, will make a presentation about “Possibilities of oligonucleotide therapeutics by using modified nucleic acid”.
We are looking forward to seeing you.
Please click here for details(Japanese only).